Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 5,130.00
+145.00 (2.91%)
At close: May 8, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 42.51 billion as of May 11, 2026. Its market cap has decreased by -43.93% in one year.
Market Cap
42.51B
Enterprise Value
44.57B
Revenue
381.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
5,130.00
Market Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 42.51B, a decrease of -64.13%. That is a compound annual growth rate of -18.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 41.43B | 48.16% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | 118.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Remed | 90.87B |
| QuantaMatrix | 78.93B |
| Noul Co.,Ltd. | 62.63B |
| DRGEM | 62.10B |
| JPI Healthcare | 60.29B |
| Genoray | 57.03B |
| MEKICS CO., | 40.14B |
| UXN Co., Ltd. | 33.23B |